1. Home
  2. ANSC vs PSNL Comparison

ANSC vs PSNL Comparison

Compare ANSC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANSC
  • PSNL
  • Stock Information
  • Founded
  • ANSC 2021
  • PSNL 2011
  • Country
  • ANSC United States
  • PSNL United States
  • Employees
  • ANSC N/A
  • PSNL N/A
  • Industry
  • ANSC
  • PSNL Medical Specialities
  • Sector
  • ANSC
  • PSNL Health Care
  • Exchange
  • ANSC Nasdaq
  • PSNL Nasdaq
  • Market Cap
  • ANSC 466.6M
  • PSNL 484.0M
  • IPO Year
  • ANSC 2023
  • PSNL 2019
  • Fundamental
  • Price
  • ANSC $10.90
  • PSNL $4.60
  • Analyst Decision
  • ANSC
  • PSNL Strong Buy
  • Analyst Count
  • ANSC 0
  • PSNL 5
  • Target Price
  • ANSC N/A
  • PSNL $7.90
  • AVG Volume (30 Days)
  • ANSC 33.8K
  • PSNL 1.1M
  • Earning Date
  • ANSC 01-01-0001
  • PSNL 08-05-2025
  • Dividend Yield
  • ANSC N/A
  • PSNL N/A
  • EPS Growth
  • ANSC N/A
  • PSNL N/A
  • EPS
  • ANSC 0.14
  • PSNL N/A
  • Revenue
  • ANSC N/A
  • PSNL $80,317,000.00
  • Revenue This Year
  • ANSC N/A
  • PSNL $0.45
  • Revenue Next Year
  • ANSC N/A
  • PSNL $25.75
  • P/E Ratio
  • ANSC $80.07
  • PSNL N/A
  • Revenue Growth
  • ANSC N/A
  • PSNL 0.36
  • 52 Week Low
  • ANSC $10.31
  • PSNL $2.83
  • 52 Week High
  • ANSC $10.93
  • PSNL $7.79
  • Technical
  • Relative Strength Index (RSI)
  • ANSC 64.66
  • PSNL 35.07
  • Support Level
  • ANSC $10.87
  • PSNL $4.57
  • Resistance Level
  • ANSC $10.87
  • PSNL $4.93
  • Average True Range (ATR)
  • ANSC 0.01
  • PSNL 0.33
  • MACD
  • ANSC -0.00
  • PSNL -0.08
  • Stochastic Oscillator
  • ANSC 100.00
  • PSNL 30.65

About ANSC Agriculture & Natural Solutions Acquisition Corporation

Agriculture & Natural Solutions Acquisition Corp is a blank check company.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: